Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

SmartTechGroup updated its dividend policy

2/5/25 CARM

T-Bank bought the Central Telegraph building

2/5/25 T

CIAN's new holding company received a public status

2/5/25 CIAN

SPX Exchange summarized the results of trading in January

2/5/25 SPBE

Fesco to increase transportation of consolidated cargoes by 19% in 2024

2/5/25 FESH

Lenta's retail revenue in 2024 to grow by 44%

2/5/25 LENT

Delimobil's revenues in 2024 to grow by 35%

2/5/25 DELI

Arenadata Group's revenue in 2024 grew by 52%

2/5/25 DATA

MD Medical's revenue in 2024 to grow by 20%

2/5/25 MDMG

MCAO Cian prepares to exchange receipts for shares

2/5/25 CIAN